scholarly article | Q13442814 |
P50 | author | John H. Alexander | Q110877755 |
Steen E Husted | Q114427074 | ||
Ziad Hijazi | Q114427140 | ||
ARISTOTLE and RE-LY Investigators | Q114427175 | ||
Michael Hanna | Q120703226 | ||
Lars Wallentin | Q6230815 | ||
Veli-Pekka Harjola | Q7918918 | ||
Elaine Hylek | Q43198009 | ||
Agneta Siegbahn | Q43407505 | ||
John McMurray | Q56633150 | ||
Christopher B. Granger | Q62050240 | ||
Dan Atar | Q65660970 | ||
John D. Horowitz | Q73022836 | ||
Renato Delascio Lopes | Q90906040 | ||
Bernard J Gersh | Q100694590 | ||
P2093 | author name string | Ulrika Andersson | |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | apixaban | Q414462 |
Atrial Fibrillation | Q815819 | ||
P304 | page(s) | 52-61 | |
P577 | publication date | 2013-09-19 | |
P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
P1476 | title | High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin. | |
P478 | volume | 63 |
Q58113170 | 27-Year-Old Man with a Positive Troponin: A Case Report |
Q50082606 | A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score |
Q98386444 | A novel scoring system for stroke risk stratification in Japanese patients with low CHADS2 scores: Study using a transesophageal-echocardiogram endpoint |
Q38876376 | Apixaban to prevent stroke in patients with atrial fibrillation: a review |
Q45839045 | Atrial fibrillation, elevated troponin, ischemic stroke and adverse outcomes: understanding the connection. |
Q26851235 | Atrial fibrillation: a review of recent studies with a focus on those from the duke clinical research institute |
Q64090263 | Biomarkers of Atrial Fibrillation: Which One Is a True Marker? |
Q64239359 | Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE - LY Trial |
Q89958685 | Cardiac Biomarkers and Subsequent Risk of Hospitalization With Bleeding in the Community: Atherosclerosis Risk in Communities Study |
Q64272119 | Development and external validation of predictive models for prevalent and recurrent atrial fibrillation: a protocol for the analysis of the CATCH ME combined dataset |
Q47654635 | Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease. |
Q41857087 | Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation? |
Q33846316 | Dynamic high-sensitivity troponin elevations in atrial fibrillation patients might not be associated with significant coronary artery disease. |
Q50119076 | Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Tria |
Q30375302 | EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication. |
Q55638585 | EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication. |
Q45939560 | EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. |
Q30235455 | High-Sensitivity Troponin as a Biomarker in Heart Rhythm Disease |
Q64238446 | High-sensitivity cardiac troponin T as an independent predictor of stroke in patients admitted to an emergency department with atrial fibrillation |
Q30854596 | High-sensitivity troponin T: a biomarker for diuretic response in decompensated heart failure patients |
Q38262571 | High-sensitivity troponin: where are we now and where do we go from here? |
Q35714803 | Identification of acute myocardial infarction in patients with atrial fibrillation and chest pain with a contemporary sensitive troponin I assay |
Q87611363 | Improved rate control reduces cardiac troponin T levels in permanent atrial fibrillation |
Q40061451 | Left Atrial Size and Long-Term Risk of Recurrent Stroke After Acute Ischemic Stroke in Patients With Nonvalvular Atrial Fibrillation |
Q41627539 | Long-Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC-Stroke and CHA2DS2-VASc Scores |
Q89678167 | New-onset lone maternal atrial fibrillation: A case report |
Q59335172 | Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial |
Q41476995 | Patients with atrial fibrillation complicated by coronary artery disease. Is a single value of sensitive cardiac troponin I on admission enough? |
Q36736475 | Predictors of Elevated Cardiac Enzyme Levels in Hospitalized Patients with Atrial Fibrillation and No Known Coronary Artery Disease. |
Q98386462 | Predictors of time to conversion of new-onset atrial fibrillation to sinus rhythm with amiodarone therapy |
Q90655710 | Prognostic significance of troponin level in 3121 patients presenting with atrial fibrillation (The NIHR Health Informatics Collaborative TROP-AF study) |
Q38377313 | Prognostic value of elevated high-sensitivity cardiac troponin T in patients admitted to an emergency department with atrial fibrillation |
Q40029271 | Regulatory Forum Opinion Piece*: Veterinary Pathologists in Translational Pharmacology and Biomarker Integration in Drug Discovery and Development |
Q38375044 | Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time |
Q36923167 | The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation |
Q88641256 | The ABC risk score for patients with atrial fibrillation |
Q46139654 | The Significance Of Troponin Elevation In Atrial Fibrillation |
Q53620115 | The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study. |
Q38499448 | Troponins and other biomarkers in the early diagnosis of acute myocardial infarction |
Search more.